Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Korean researchers report preclinical toxicity and pharmacokinetics of CKD-602 continuous infusion

April 16, 1999

In vitro and in vivo profile of AG-7352 described in further detail at AACR meeting

April 16, 1999

Pharmacokinetics and MTD of BBR-2778 determined in cancer patients

April 16, 1999

Differentiation-inducing vitamin D derivatives described by Teikoku Hormone

April 16, 1999

News from AACR: chemopreventive properties of NSAIDs, including COX-2 inhibitors

April 16, 1999

Celsion signs option agreement for cancer therapy technology

April 16, 1999

New distamycin derivative PNU-166196 exerts both antiproliferative and apoptotic effects

April 15, 1999

Antisense oligonucleotides targeting Bcl-x developed and evaluated at Isis

April 15, 1999

Ontogen's OC144-093 reported at AACR meeting to merit further clinical testing

April 15, 1999

TAS-106, a promising antitumor nucleoside profiled at AACR meeting

April 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...